Voluven is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira Inc.. The primary component is Hydroxyethyl Starch 130/0.4.
| Product ID | 0409-1029_4cf79958-bba6-4ab0-b970-92b80ce04439 |
| NDC | 0409-1029 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Voluven |
| Generic Name | Hydroxyethyl Starch 130/0.4 |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-06-25 |
| Marketing Category | NDA / NDA |
| Application Number | BN070012 |
| Labeler Name | Hospira Inc. |
| Substance Name | HYDROXYETHYL STARCH 130/0.4 |
| Active Ingredient Strength | 6 g/100mL |
| Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-06-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | BN070012 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-11-07 |
| Marketing End Date | 2020-02-28 |
| Marketing Category | NDA |
| Application Number | BN070012 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-06-25 |
| Marketing End Date | 2020-02-28 |
| Marketing Category | NDA |
| Application Number | BN070012 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-15 |
| Marketing End Date | 2020-02-28 |
| Ingredient | Strength |
|---|---|
| HYDROXYETHYL STARCH 130/0.4 | 6 g/100mL |
| SPL SET ID: | c2c45e02-5d9a-4a54-f291-e5b54671b08b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VOLUVEN 75921641 2497816 Live/Registered |
FRESENIUS SE & CO. KGAA 2000-02-16 |